UPenn HIV Grand Rounds - Home Page

 

Jointly Sponsored by: Perelman School of Medicine at the University of Pennsylvania, The Penn Center for AIDS Research and ViralEd, Inc.
 

Live Series Schedule

About the Program

Program Overview

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.

Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access. 

Back to Top

Target Audience

This program has been designed for Family Medicine, Pediatrics, Neurology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease

Back to Top

Commercial Support Acknowledgement

HIV Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs,  ViiV Healthcare, Janssen Therapeutics and Merck Sharp and Dohme Corp.

Back to Top

Learning Objectives

After completing this activity, participants should be better able to:

  • Apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients rapidly into care
  • Individualize ARV therapy for the treatment-naïve and treatment-experienced patients to support adherence and patient satisfaction
  • Manage various patient populations, such as the aging patient with HIV infection, including issues associated with cardiovascular and bone disease, PWIDs and underserved populations
  • Understand the basic science concepts involved with HIV and be able to apply those concepts to HIV therapeutics and other issues involved in HIV patient care and HIV prevention
Back to Top

Course Directors

Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania

Katherine Bar, MD
Assistant Professor
Department of Medicine
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania

Next Session and Participation Information

Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand

  • Delivered via webinar directly to you  and/or your clinic
  • You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
  • Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device

If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.

Back to Top

Live Session Topics and Speakers


January 20, 2022

The Top Ten Publications in HIV Infection in 2021

Ian Frank, MD

Click HERE to View On-Demand


January 27, 2022

Antibody therapeutics for COVID-19

Katherine Bar, MD

Click HERE to View On-Demand


February 3, 2022

Towards the Development of Gender Responsive Interventions to Improve Men’s Engagement in TB Care and Treatment

Andrew Marino-Medina, PhD

Click HERE to View On-Demand


February 10, 2022

Clinical Cases on PrEP

Richard Elion, MD

Click HERE to View On-Demand


February 24, 2022

COVID-19 Therapeutic Update

Kathleen Degnan, MD

Click HERE to View On-Demand


March 3, 2022

Cell-Intrinsic Resistance to CTL in the HIV Reservoir

R. Brad Jones, PhD

Click HERE to View On-Demand


March 10, 2022

Highlights from Virtual CROI 2022 - The COVID-19 Data

Ian Frank, MD

Click HERE to View On-Demand


March 17, 2022

Highlights from Virtual CROI 2022

Paul Sax, MD

Click HERE to View On-Demand


March 24, 2022

Facilitating the Application of Implementation Science in HIV Programs and Research in Nigeria and West/Central Africa

Nadia A. Sam-Agudu, MD

Click HERE to View On-Demand


March 31, 2022

Sexual Health Clinic Outcomes and PrEP Linkage in a Large Urban Emergency Department

Anu Hazra, MD

Click HERE to View On-Demand


April 7, 2022

Mechanisms of HIV persistence - a single-cell multi-omics approach

Ya-Chi Ho, MD, PhD

Click HERE to View On-Demand


April 14, 2022

Real Cases from the University of Pennsylvania

Ian Frank, MD; Helen Koenig, MD and William Short, MD

Click HERE to View On-Demand


April 21, 2022

Design insights for gene-editing a cure for HIV

Michael Nonnemacher, PhD

Click HERE to View On-Demand


April 28, 2022

Antiretroviral Therapy and Weight Gain

Roger Bedimo, MD

Click HERE to View On-Demand


May 5, 2022

Understanding Processes of Communication Leading to Behavioral Change: The Case of COVID-19 and Other Infections in the United States

Dolores Albarracin, PhD

Click HERE to View On-Demand


May 19, 2022

COVID-19 Prevention: A Human Rights Based Approach

Renslow Sherer, MD

Click HERE to View On-Demand


May 26, 2022

Using Evidence to Take Integrated Care to People Who Use Drugs

Steven Shoptaw, PhD

Click HERE to View On-Demand


June 2, 2022

Meeting the Challenges of a Pandemic at the Laboratory Level: Stories of SARS-CoV-2 Variants, Vaccines and Immune Correlates

David Montefiori, PhD

Click HERE to View On-Demand


June 9, 2022

Syphilis: Mercury, Malaria, and Mystery

Sara Clemens, MD

Click HERE to View On-Demand


June 16, 2022

Effective community engagement strategies used to support diverse broad awareness and participation in COVID-19 vaccine trials

Stephaun Wallace, PhD

Click HERE to View On-Demand


June 23, 2022

TB preventive treatment: progress, challenges & opportunities

Professor Gavin Churchyard

Click HERE to View On-Demand


June 30, 2022

COVID-19 Vaccines: An International Perspective

Dr Nigel Garrett, MBBS, MRCP, MSc, PhD

Click HERE to View On-Demand


September 8, 2022

Highlights from AIDS 2022

Ian Frank, MD

Click HERE to View On-Demand


September 15, 2022

Caring for patients living with HIV and Opioid Use Disorder

Jessica Meisner, MD, MS, MSHP

Click HERE to View On-Demand


September 22, 2022

Changes in standard of care and their impact on mortality during  COVID-19

Pablo Tebas, MD

Click HERE to View On-Demand


September 29, 2022

A Systems Approach for Understanding HIV Disparities in Racial, Ethnic, and Sexual Minority Populations

Michelle Birkett, PhD

Click HERE to View On-Demand


October 6, 2022

Real Cases from the University of Pennsylvania

Ian Frank, MD

Click HERE to View On-Demand


October 13, 2022

TBD

TBD

Click HERE to Register


October 20, 2022

Ending the HIV Epidemic in New York City

Sarah Braunstein, PhD

Click HERE to Register


 

October 27, 2022

A Converation with the London Patient, Adam Castillejo

Ian Frank, MD and Adam Castillejo

Click HERE to Register

 

 


 

TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW:
 

 

 

 

Back to Top

 

 

Hardware/Software Notice

You will need Internet to participate in this activity.

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE)  have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee Members:

  • ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:


Ian Frank, MD (Program Co-director)

  • Advisor or Review Panel Member: Gilead; GlaxoSmithKline
  • Consultant: Merck
  • Grant/Research Support Recipient: Johnson & Johnson; Moderna; Sanofi Pasteur

Katherin Bar, MD (Program Co-director)

  • Consultant: Abbvie
Back to Top

Discussion of Investigational and/or Off-label Use of Commercial Products and Devices

The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

   

    UPenn CME - 2019          VE Logo 2019           CFAR 2019

     



 

 

Back to Top

 

Prepare to print

Share this page:

Get link code to this page     


Back to Top